Our study revealed the inhibitory effects of ESRRG on the growth, tumorigenesis, and glycolysis activity of ESCC cells, which were mediated by the downregulation of PKM2 expression. This evidence concerns the gene ESRRG and esophageal squamous cell carcinoma.